Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 9th DDR Inhibitors Summit.

Jenn Castro

Director - Translational & Discovery Biology
Accent Therapeutics

Michail Shipitsin

Vice President Biomarker Development
Acrivon Therapeutics

Ian Smith

Chief Medical Officer
Artios Pharma

Graeme Smith

Chief Scientific Officer
Artios Pharma

Angela Carvalho

Co-Founder & Chief Executive Officer
Beat Therapeutics

Jon Hollick

Managing Director & Head of Research
Breakpoint Therapeutics

Michael Torres

CEO & Co-Founder
CrossBridge Bio

Alan D’Andrea

Director of the Center for DNA Damage and Repair
Dana-Farber Cancer Institute

Luke Piggott

Director of Business Development and Principal Scientist
Debiopharm

Jatinder Mukker

Head Senior Director, Quantitative Pharmacology Portfolio Section
EMD Serono, an affiliate of Merck KGaA

Ioannis Gounaris

Vice President - Clinical Development
EMD Serono, an affiliate of Merck KGaA

Irena Konstantinova

Head of Biology
FoRx Therapeutics AG

Samuel Rabkin

Professor of Neurosurgery
Massachusetts General Hospital and Harvard Medical School

Jann Sarkaria

Professor - Radiation Oncology
Mayo Clinic

Ranjit Bindra

Co-Founder & Professor, Co-Director, Brain Tumor Center
Modifi Bio
Julian Blagg

Julian Blagg

VP Drug Discovery & Chair of Scientific Advisory Board
NeoPhore

Katherine Pawelczak

Chief Operating Officer & Vice President - Research
Nerx BioSciences Inc.

Shridar Ganesan

Director, Center for Molecular Oncology
Perlmutter Cancer NYU Langone Health

Jack Cheng

Associate Director
PharmaEngine, Inc

Mads Daugaard

Co-founder, President & Chief Scientific Officer
Rakovina Therapeutics, Inc.

Sotirios Sotiriou

Principal Scientist
Roche

Philip Beer

Chief Scientific Officer
Step Pharma

Yuka Kumagai

Senior Vice President, Head of Translational Research & Medicine
Sumitomo Pharma America, Inc.
Genevive Hernandez

Genevive Hernandez

Executive Director, Biomarkers Research & Translational Sciences
Sutro Biopharma

Tim Yap

Vice President and Head of Clinical Development, Therapeutics Discovery Division
The University of Texas MD Anderson Cancer Center

Zakia BELAID-SANDAL

CEO
Theranovir

Anthony Chalmers

Professor & Clinical Oncology Chair
University of Glasgow

Ivan Ahel

EP Abraham Professor of Chemical Pathology
University of Oxford

Eric J. Brown

Associate Professor
University of Pennsylvania
Roger G

Roger Greenberg

Professor of Cancer Biology
University of Pennsylvania

David Mankoff

Professor and Vice-Chair for Research of Radiology; SAB Co-Chair, Trevar
University of Pennsylvania

Hyunho LEE

Chief Technology Officer and Head of R&D
VSPharmTech

Wei Zhong

Chief Executive Officer
Wayshine Biopharm
Viewing poster
Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.

View Presentations & Speakers
Explaining poster
Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Explore Sponsorship Options
poster session socialising
Join DDR Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.

Register Now